Global Micafungin Sodium Powder for Injection Market is projected to reach USD 302 million by 2034

According to a newly published market research report by 24LifeSciences, Global Micafungin Sodium Powder for Injection Market was valued at USD 241 million in 2026 and is projected to reach USD 302 million by 2034, growing at a compound annual growth rate (CAGR) of 3.4% during the forecast period 2026 -2034. Micafungin sodium, an essential member of the echinocandin class of antifungal agents, is widely recognized for its critical role in combating serious systemic fungal infections. Marketed under brand names such as Mycamine (Astellas Pharma Inc.) and Funguard, alongside various generic formulations, this injectable medication has become a cornerstone in hospital formularies worldwide. Its mechanism of action, which involves the precise inhibition of -(1,3)-D-glucan synthesisa vital component of the fungal cell walldisrupts cellular integrity, leading to osmotic instability and fungal cell death. This targeted approach provides potent efficacy against a broad spectrum of Candida and